The ROE as of September 2024 (TTM) for Coeptis Therapeutics, Inc. (COEP) is -308.83%

According to Coeptis Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -308.83%. This represents a change of 281.81% compared to the average of -80.88% of the last 4 quarters.

Coeptis Therapeutics, Inc. (COEP) Historical ROE (quarterly & annually)

How has COEP ROE performed in the past?

The mean historical ROE of Coeptis Therapeutics, Inc. over the last ten years is -347.22%. The current -308.83% ROE has changed -11.06% with respect to the historical average. Over the past ten years (40 quarters), COEP's ROE was at its highest in in the November 2020 quarter at 1.08%. The ROE was at its lowest in in the March 2022 quarter at -145840555.87%.

Coeptis Therapeutics, Inc. (COEP) ROE by Quarter and Year

Discovering the peaks and valleys of Coeptis Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Coeptis Therapeutics, Inc. (COEP) Average ROE

How has COEP ROE performed in the past?

The current ROE of Coeptis Therapeutics, Inc. (COEP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Coeptis Therapeutics, Inc. (COEP) ROE vs. Peers

How is COEP’s ROE compared to its peers?

Coeptis Therapeutics, Inc.’s ROE is less than SeaStar Medical Holding Corporation (323.08%), greater than Virios Therapeutics, Inc. (-130.35%), greater than ZyVersa Therapeutics, Inc. (-172.51%), greater than Sonnet BioTherapeutics Holdings, Inc. (-398.33%), greater than Revelation Biosciences, Inc. (-243.91%), greater than Clearmind Medicine Inc. (-205.09%), greater than Hillstream BioPharma, Inc. (-47249.59%), greater than Magenta Therapeutics, Inc. (-61.71%), greater than Quoin Pharmaceuticals, Ltd. (-112.11%), greater than Genelux Corporation (-110.28%), less than Comera Life Sciences Holdings, Inc. (1.54%), greater than Dyadic International, Inc. (-145.95%), less than Cingulate Inc. (11.47%), greater than Monopar Therapeutics Inc. (-110.60%), greater than YS Biopharma Co., Ltd. (-50.46%), greater than Allarity Therapeutics, Inc. (-704.78%), less than Kiromic BioPharma, Inc. (337.72%), greater than Aditxt, Inc. (-607.01%), greater than Palisade Bio, Inc. (-124.86%), less than Plus Therapeutics, Inc. (473.01%),

Build a custom stock screener for Coeptis Therapeutics, Inc. (COEP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Coeptis Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Coeptis Therapeutics, Inc. (COEP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Coeptis Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.